{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:34:55Z","timestamp":1777952095720,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA015969-09S1"],"award-info":[{"award-number":["R01 DA015969-09S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50-DA09241"],"award-info":[{"award-number":["P50-DA09241"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA041661"],"award-info":[{"award-number":["R21DA041661"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10 DA015831"],"award-info":[{"award-number":["U10 DA015831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA030369-04S1"],"award-info":[{"award-number":["R01DA030369-04S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017-22004-9"],"award-info":[{"award-number":["2017-22004-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017-05371-8"],"award-info":[{"award-number":["2017-05371-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.drugalcdep.2019.01.046","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T10:39:03Z","timestamp":1553078343000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders"],"prefix":"10.1016","volume":"198","author":[{"given":"Andr\u00e9 Q.C.","family":"Miguel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Kiluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa A.","family":"Babuscio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charla","family":"Nich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair J.","family":"Mari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1037\/adb0000311","article-title":"Cognitive behavioral interventions for alcohol and drug use disorders: through the stage model and back again","volume":"3","author":"Carroll","year":"2017","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0015","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archpsyc.1994.03950120061010","article-title":"One-Year follow-up of psychotherapy and pharmacotherapy for cocaine dependence delayed emergence of psychotherapy effects","volume":"51","author":"Carroll","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1176\/appi.ajp.2008.07111835","article-title":"Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT","volume":"165","author":"Carroll","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.drugalcdep.2012.05.019","article-title":"Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial","volume":"126","author":"Carroll","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2014.01.012","article-title":"Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes","volume":"137","author":"Carroll","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1176\/appi.ajp.2013.13070987","article-title":"Computer-assisted delivery of cognitive-behavioral therapy: Efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone","volume":"171","author":"Carroll","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2015.12.036","article-title":"A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence","volume":"160","author":"Carroll","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0045","first-page":"79","article-title":"Galantamine and computerized cognitive behavioral therapy for cocaine dependence: a randomized clinical trial","author":"Carroll","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0193-953X(02)00106-5","article-title":"Outcome predictors in substance use disorders","volume":"26","author":"Ciraulo","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2008.05.005","article-title":"Meta-analysis of depression and substance use and impairment among cocaine users","volume":"98","author":"Conner","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0065","series-title":"The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual","author":"Derogatis","year":"1993"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291700048017","article-title":"The brief symptom inventory - an introductory report","volume":"13","author":"Derogatis","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0075","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1360-0443.2011.03473.x","article-title":"Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials","volume":"107","author":"Donovan","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0085","series-title":"Probuphine (Buprenorphine Hydrochloride Subdermal Implant) for Maintenance Treatment of Opioid Dependence","author":"Food and Drug Administration: Psychopharmacologic Drugs Advisory Committee","year":"2013"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2008.07.004","article-title":"Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals","volume":"99","author":"Ford","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0095","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders - results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1037\/0022-006X.68.1.64","article-title":"Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up","volume":"68","author":"Higgins","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/1462220031000070552","article-title":"Measures of abstinence in clinical trials: issues and recommendations","volume":"5","author":"Hughes","year":"2003","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0110","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.addbeh.2006.12.007","article-title":"Psychiatric symptomatology among individuals in alcohol detoxification treatment","volume":"32","author":"Johnson","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1037\/a0036245","article-title":"What happens in treatment doesn\u2019t stay in treatment: cocaine abstinence during treatment is associated with fewer problems at follow-up","volume":"82","author":"Kiluk","year":"2014","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.11.004","article-title":"Measures of outcome for stimulant trials: ACTTION recommendations and research agenda","volume":"158","author":"Kiluk","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0125","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.drugalcdep.2017.07.020","article-title":"Initial validation of a proxy indicator of functioning as a potential tool for establishing a clinically meaningful cocaine use outcome","volume":"179","author":"Kiluk","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0130","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1037\/pha0000147","article-title":"Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals","volume":"25","author":"Miguel","year":"2017","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1037\/a0032499","article-title":"Contingency management treatments decrease psychiatric symptoms","volume":"81","author":"Petry","year":"2013","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jsat.2010.02.003","article-title":"Sober living houses for alcohol and drug dependence: 18-month outcomes","volume":"38","author":"Polcin","year":"2010","journal-title":"J. Subs. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1037\/a0030992","article-title":"Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use","volume":"28","author":"Robinson","year":"2014","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0155","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1176\/ajp.2006.163.11.1993","article-title":"Contingency management for the treatment of methamphetamine use disorders","volume":"163","author":"Roll","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0160","series-title":"Measuring Alcohol Consumption","article-title":"Timeline follow-back","author":"Sobell","year":"1992"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1360-0443.2011.03581.x","article-title":"Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders","volume":"107","author":"Tiffany","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addbeh.2009.08.003","article-title":"Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users","volume":"35","author":"Wang","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1755-5949.2011.00288.x","article-title":"Reanalysis of methamphetamine dependence treatment trial","volume":"18","author":"Winchell","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.drugalcdep.2019.01.046_bib0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1360-0443.2003.00311.x","article-title":"Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report","volume":"98","author":"Winhusen","year":"2003","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161930078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161930078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:43:04Z","timestamp":1777894984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161930078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":36,"alternative-id":["S037687161930078X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.046","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}